Literature DB >> 18260745

Bilateral male breast cancer: too many concerns?

Vitorino Modesto dos Santos, Ernesto Misael Cintra Osterne, Rodrigo Aires de Castro, Herberth Vera Cruz Furtado Marques.   

Abstract

The male breast cancer accounts for nearly 1% of all breast cancer cases and bilateral involvement occurs in less than 2% of the cases. Estrogen treatment for prostate cancer is a risk factor for primary breast cancer. Bilateral breast carcinomas were found in a 79-year-old Brazilian black man, following prostate cancer treatment with estrogen. Prostate cancer metastases could be found in breast tissue, and might be indistinguishable from primary breast tumours on histological evaluation without immunohistochemistry. Coexistence of prostate cancer with breast cancer increases future-longevity concerns.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18260745

Source DB:  PubMed          Journal:  Asian Pac J Cancer Prev        ISSN: 1513-7368


  5 in total

1.  Male breast cancer: presenting as synchronous, large, bilateral masses.

Authors:  Sunil Vitthalrao Jagtap; P G Chougule; Wasim Khatib; Dhirajkumar B Shukla; Swati Sunil Jagtap
Journal:  J Clin Diagn Res       Date:  2014-04-15

2.  Bilateral Synchronous Breast Cancer in Elderly Male.

Authors:  Sachin S Kadam; Gajanan Kanitkar; Shilpy Dolas; Saurabh Phadke
Journal:  Indian J Surg Oncol       Date:  2019-12-11

Review 3.  Male breast cancer: an update in diagnosis, treatment and molecular profiling.

Authors:  Susan Onami; Melanie Ozaki; Joanne E Mortimer; Sumanta Kumar Pal
Journal:  Maturitas       Date:  2010-02-06       Impact factor: 4.342

4.  Male patients with unilateral breast symptoms: an optimal imaging approach.

Authors:  Bora Yoon; Eun Young Chae; Joo Hee Cha; Hee Jung Shin; Woo Jung Choi; Hak Hee Kim
Journal:  Eur Radiol       Date:  2020-04-03       Impact factor: 5.315

5.  Bilateral synchronous male breast cancer.

Authors:  Nnamdi J Nwashilli; Ezekiel E Ugiagbe
Journal:  Saudi Med J       Date:  2015-03       Impact factor: 1.484

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.